From 3D Cell Culture System to PersonalizedMedicine in Osteosarcoma

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Unknown venue

• Publication date

  2019-05-15

• Fields of study

  Biology, Medicine, Engineering

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Three‐Dimensional Osteosarcoma Models for Advancing Drug Discovery and Development

  2018influential reference
• Osteosarcoma: a comprehensive review

  2018cited by this paper
• Relevance of 3d culture systems to study osteosarcoma environment

  2018cited by this paper
• Combining 2D angiogenesis and 3D osteosarcoma microtissues to improve vascularization

  2017cited by this paper
• Role of tumor microenvironment in tumorigenesis

  2017cited by this paper
• 3D high-resolution two-photon crosslinked hydrogel structures for biological studies.

  2017cited by this paper
• miR-335 negatively regulates osteosarcoma stem cell-like properties by targeting POU5F1

  2017cited by this paper
• Future directions in the treatment of osteosarcoma

  2016cited by this paper
• Real-time monitoring of cisplatin cytotoxicity on three-dimensional spheroid tumor cells

  2016cited by this paper
• A practical guide to hydrogels for cell culture

  2016cited by this paper
• Prognostic value of inflammation-based scores in patients with osteosarcoma

  2016cited by this paper
• New horizons in tumor microenvironment biology: challenges and opportunities

  2015cited by this paper
• Optimum 3D Matrix Stiffness for Maintenance of Cancer Stem Cells Is Dependent on Tissue Origin of Cancer Cells

  2015cited by this paper
• Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies.

  2015cited by this paper
• Improved Survival in Osteosarcoma Patients with Atypical Low Vascularization

  2015cited by this paper
• Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer.

  2015cited by this paper
• The need for complex 3D culture models to unravel novel pathways and identify accurate biomarkers in breast cancer.

  2014influential reference
• Advanced Cell Culture Techniques for Cancer Drug Discovery

  2014influential reference
• Embedded multicellular spheroids as a biomimetic 3D cancer model for evaluating drug and drug-device combinations.

  2014cited by this paper
• Molecular mechanisms of chemoresistance in osteosarcoma (Review)

  2014cited by this paper
• Global Gene Expression Analysis of Canine Osteosarcoma Stem Cells Reveals a Novel Role for COX-2 in Tumour Initiation

  2014cited by this paper
• Epigenetic alterations in osteosarcoma: promising targets

  2014cited by this paper
• Translational biology of osteosarcoma

  2014cited by this paper
• The Dominant Role of IL-8 as an Angiogenic Driver in a Three-Dimensional Physiological Tumor Construct for Drug Testing

  2014cited by this paper
• Recent advances in osteosarcoma.

  2014cited by this paper
• An in vitro osteosarcoma 3D microtissue model for drug development.

  2014cited by this paper
• Proteomic approach toward molecular backgrounds of drug resistance of osteosarcoma cells in spheroid culture system

  2013cited by this paper
• Three-dimensional cultures of mouse mammary epithelial cells.

  2013cited by this paper
• Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysis.

  2013cited by this paper
• Microarray expression profile of long noncoding RNAs in human osteosarcoma.

  2013cited by this paper
• Lysine-specific demethylase 1 (LSD1/KDM1A/AOF2/BHC110) is expressed and is an epigenetic drug target in chondrosarcoma, Ewing's sarcoma, osteosarcoma, and rhabdomyosarcoma.

  2012cited by this paper
• MicroRNA Involvement in Osteosarcoma

  2012cited by this paper
• The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway.

  2012cited by this paper
• Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line

  2012cited by this paper
• A simple hanging drop cell culture protocol for generation of 3D spheroids.

  2011cited by this paper
• Identification and gene expression profiling of tumor-initiating cells isolated from human osteosarcoma cell lines in an orthotopic mouse model

  2011cited by this paper
• Three-dimensional porous silk tumor constructs in the approximation of in vivo osteosarcoma physiology.

  2011cited by this paper
• Addition of pamidronate to chemotherapy for the treatment of osteosarcoma

  2011cited by this paper
• Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma

  2011cited by this paper
• Good prognosis of localized osteosarcoma in young patients treated with limb‐salvage surgery and chemotherapy

  2011cited by this paper
• Personalized medicine: part 1: evolution and development into theranostics.

  2010cited by this paper
• Genomic Alterations and Allelic Imbalances Are Strong Prognostic Predictors in Osteosarcoma

  2010cited by this paper
• Osteosarcoma: a review of diagnosis, management, and treatment strategies.

  2010cited by this paper
• Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma.

  2010cited by this paper
• International osteosarcoma incidence patterns in children and adolescents, middle ages and elderly persons

  2009cited by this paper
• Cancer-related inflammation

  2008cited by this paper
• Aberrant Methylation of p14ARF Gene Correlates with Poor Survival in Osteosarcoma

  2006cited by this paper
• Primary bone osteosarcoma in the pediatric age: state of the art.

  2006cited by this paper
• Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).

  2005cited by this paper
• Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols.

  2002cited by this paper
• Amplification of 17p11.2 approximately p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma.

  2002cited by this paper
• Taking Cell-Matrix Adhesions to the Third Dimension

  2001cited by this paper
• Alteration of pRb/p16/cdk4 regulation in human osteosarcoma

  1999cited by this paper
• Alterations of the p53, Rb and MDM2 genes in osteosarcoma.

  1996cited by this paper
• The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

  1986cited by this paper
• Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma.

  1974cited by this paper

• Macroporous alginate scaffolds with calcium phosphate filler as a 3D in vitro microenvironment supporting bone cancer cells

  2025cites this paper
• Biomechanical Aspects in Bone Tumor Engineering

  2023cites this paper